Napodano, Cecilia
 Distribuzione geografica
Continente #
NA - Nord America 2.489
AS - Asia 1.862
EU - Europa 1.494
SA - Sud America 351
AF - Africa 52
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.261
Nazione #
US - Stati Uniti d'America 2.410
SG - Singapore 936
SE - Svezia 429
CN - Cina 367
BR - Brasile 297
IT - Italia 267
DE - Germania 182
VN - Vietnam 164
FR - Francia 155
GB - Regno Unito 99
IE - Irlanda 99
IN - India 76
JP - Giappone 57
ID - Indonesia 53
RU - Federazione Russa 52
BD - Bangladesh 48
FI - Finlandia 47
CA - Canada 36
HK - Hong Kong 33
MX - Messico 29
PL - Polonia 24
ES - Italia 19
TR - Turchia 19
AR - Argentina 18
BE - Belgio 18
ZA - Sudafrica 18
IQ - Iraq 17
NL - Olanda 16
UA - Ucraina 16
KR - Corea 15
MA - Marocco 10
AT - Austria 9
CZ - Repubblica Ceca 9
AE - Emirati Arabi Uniti 8
IR - Iran 8
PK - Pakistan 8
CH - Svizzera 7
CI - Costa d'Avorio 7
CO - Colombia 7
EC - Ecuador 7
LT - Lituania 7
MY - Malesia 7
SA - Arabia Saudita 7
AU - Australia 6
BY - Bielorussia 6
GR - Grecia 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
CL - Cile 5
DK - Danimarca 5
UZ - Uzbekistan 5
VE - Venezuela 5
BG - Bulgaria 4
DZ - Algeria 4
EG - Egitto 4
GY - Guiana 4
JM - Giamaica 4
JO - Giordania 4
KE - Kenya 4
LB - Libano 4
PH - Filippine 4
PY - Paraguay 4
HU - Ungheria 3
KZ - Kazakistan 3
RO - Romania 3
TN - Tunisia 3
AL - Albania 2
HN - Honduras 2
MM - Myanmar 2
NP - Nepal 2
PE - Perù 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CY - Cipro 1
EU - Europa 1
GE - Georgia 1
HR - Croazia 1
HT - Haiti 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
MQ - Martinica 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 6.261
Città #
Singapore 568
Chandler 383
Ashburn 265
San Jose 230
New York 129
Dublin 99
Beijing 96
Dallas 81
Rome 73
Los Angeles 64
Frankfurt am Main 56
Tokyo 54
Lauterbourg 52
Ho Chi Minh City 50
Jakarta 50
San Mateo 49
The Dalles 49
Munich 40
Boston 39
Helsinki 37
Hanoi 36
São Paulo 36
Princeton 35
Moscow 34
Hefei 33
Council Bluffs 32
Marseille 32
North Bergen 31
Hong Kong 30
Wilmington 30
Milan 25
Orem 23
Chicago 22
Fairfield 22
Cattolica 20
Houston 20
Boardman 19
Nanjing 19
Da Nang 18
Chennai 16
Redwood City 15
Santa Clara 15
Warsaw 15
Atlanta 14
Bologna 14
Bremen 14
Castelnuovo di Val di Cecina 14
Dearborn 14
Falls Church 14
Johannesburg 14
Montreal 14
Brussels 13
Denver 13
London 13
Poplar 13
Stockholm 13
Jacksonville 12
Mexico City 12
Norwalk 12
Seattle 12
Edinburgh 11
Hyderabad 11
Nuremberg 11
San Francisco 11
Seoul 11
Buffalo 10
Kent 10
Amsterdam 9
Bexley 9
Brooklyn 9
Hebei 9
Paris 9
Woodbridge 9
Manchester 8
Querétaro 8
Rio de Janeiro 8
Shenyang 8
Toronto 8
Abidjan 7
Ann Arbor 7
Augusta 7
Baghdad 7
Dhaka 7
Falkenstein 7
Guangzhou 7
Brno 6
Minsk 6
New Delhi 6
Phoenix 6
Roubaix 6
Shanghai 6
Tukwila 6
Auckland 5
Belo Horizonte 5
Curitiba 5
Düsseldorf 5
Lancaster 5
Palermo 5
Wroclaw 5
Ankara 4
Totale 3.566
Nome #
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 190
Immune dyscrasia in adult growth hormone deficiency: Evaluation of hemolytic complement activity (CH50) and IgG subclasses 171
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 170
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 165
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 165
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 156
Evaluation of screening method for Bence Jones protein analysis 155
Immunological role of IgG subclasses 154
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace 149
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 146
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data 143
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 142
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 142
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 140
Laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis 140
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 137
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 135
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 135
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 135
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome 134
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 134
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 128
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 128
Immunological role of IgG subclasses 127
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 126
Free light chains a novel biomarker of cardiovascular disease. A pilot study. 125
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 124
Comparison of Fully Automated and Semiautomated Systems for Protein Immunofixation Electrophoresis 123
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 122
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins 122
Urinary lithogenic profile of patients with non-alcoholic fatty liver disease 121
The Laboratory Role in anti-TNF Biological Therapy Era 120
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 116
Heavy chain disease: Our experience 110
Serum free light chain quantitative assays: Dilemma of a biomarker 110
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma 109
IgG cryoglobulinemia 109
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 105
COVID-19, adaptative immune response and metabolic-associated liver disease 104
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 102
Plasmatic free light chains as inflammatory marker in insulin resistance: comparison of metabolic syndrome with adult growth hormone deficiency 102
Cryoglobulins: putative effectors of adaptive immune response 101
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 101
The dark side of current analytic methods for Bence Jones Proteinuria 100
Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus 99
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 98
General Practitioner databaSe NAFLD (GPS-NAFLD) Study: preva-lence of advanced liver fibrosis among Italian primary care pa-tients with NAFLD 94
Free light chains and autoimmunity 88
Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD) 82
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study 81
Cryoproteins in Non-HCV-Related Autoimmune Disorders: A Serious Cold-Induced Problem 71
Serum-free light chains as a dependable biomarker for stratifying patients with metabolic dysfunction-associated steatotic liver disease 3
Cryoglobulinemia and Cryofibrinogenemia: Ten years of experience and diagnostic perspectives from a large laboratory-based cohort 3
Totale 6.392
Categoria #
all - tutte 27.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.439


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 0 0 0 0 0 0 0 41
2021/2022396 11 2 5 69 30 16 11 62 20 16 65 89
2022/20231.131 177 145 74 168 67 118 71 89 119 17 63 23
2023/2024581 31 144 8 54 15 107 46 24 8 25 52 67
2024/20251.144 53 37 83 46 102 52 21 60 172 110 217 191
2025/20262.750 360 57 203 393 532 140 490 130 158 172 75 40
Totale 6.392